Live
PharmaVoiceWhen reliability becomes patient care in nuclear medicineBioPharma DivePrecision in motion: Decoding the critical operations behind the logistics of next-generation cell and gene therapiesBioPharma DiveThe capacity crunch in biopharma is a location problemFierceBiotechQuantum firm hailed by Amgen tech leader as an ‘extraordinary platform’ plans IPOFierceBiotechMRD as a Decision Engine: Rethinking Oncology Trial Design from Early Phase to RegistrationClinical OMICsEndometriosis May Increase Risk of Birth DefectsBoston ScientificBoston Scientific (BSX) Valuation Check After New Atrial Fibrillation And Stroke Prevention Data - simplywall.stAgilentAgilent Taps Cirena To Turn Long RNA Technology Into Genome Editing Growth - Yahoo FinanceScience Daily BiotechScientists successfully transfer longevity gene and extend lifespanLonza NewsLonza says big pharma might delay outsourcing decisions amid US investments - MSNSiemens HealthineersSiemens Healthineers: Update Post The Carve-Out Announcement (OTCMKTS:SEMHF) - Seeking AlphaRecursionA Look At Recursion Pharmaceuticals (RXRX) Valuation After Recent Clinical And Cost Management Updates - simplywall.st
Endpoints News Mar 26, 2026

UCB picks Georgia for $2B biologics site; AbbVie exec visits China

UCB picks Georgia for $2B biologics site; AbbVie exec visits China

Original
Body unavailable. Use the original source.